Lung carcinoma
Summary
Available tests
Check Related conditions for additional relevant tests.
- Pasche et al., 2014Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design.
- NICE, 2023UK NICE guideline NG122, Lung cancer: diagnosis and management, 2023
- AHRQ, 2013Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.